We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

92 hedge funds and large institutions have $17.8M invested in Zomedica Corp. in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 9

42% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 12

26% more capital invested

Capital invested by funds: $14.1M → $17.8M (+$3.7M)

6% more funds holding

Funds holding: 8792 (+5)

Holders
92
Holders Change
+5
Holders Change %
+5.75%
% of All Funds
1.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
18
Reduced
9
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CSB
101
City State Bank
Iowa
-$1K -3,500 Closed
SC
102
SouthState Corp
Florida
-$460 -2,750 Closed
FFA
103
Farther Finance Advisors
California
-$168 -1,008 Closed
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
+$12 +66 +2%

ZOM Hedge Fund Activity: Q4 2023 in Review

92 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2023, worth a combined $17.8M — up 26% from $14.1M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ZOM positions and 12 closed out — a net gain of 5 holders — while 18 added to existing stakes and 9 trimmed.

The largest buyer was Connective Capital Management, opening a new position worth an estimated $211K. The largest seller was ProShare Advisors, cutting an estimated $72.8K.

  • 92 institutional investors held Zomedica Corp. (ZOM) as of Q4 2023, up from 87 in Q3 2023.
  • Funds reported $17.8M of Zomedica Corp. stock for Q4 2023, up 26% quarter-over-quarter.
  • 17 funds opened new Zomedica Corp. positions in Q4 2023 and 12 closed out, a net change of +5 holders.
  • The largest Zomedica Corp. buyer in Q4 2023 was Connective Capital Management, an estimated $211K added.
  • The largest Zomedica Corp. seller in Q4 2023 was ProShare Advisors, an estimated $72.8K sold.

Based on aggregated 13F filings for Q4 2023.